Avexima OJSC is a full-service Russian pharmaceutical company. Main areas of work: synthesis of active pharmaceutical substances, development, production and promotion of modern medicines.
We do everything possible to ensure that people get sick as little as possible and recover faster, live a full life and enjoy every day of it.
We are improving all stages of drug development, introducing new approaches, building constructive business processes and modernizing pharmaceutical production facilities in order to create high-demand medicines.
Every step from the development to the production of medicines is under strict control, which allows us to guarantee the safety and effectiveness of the product. We are aware of our responsibility and are proud to bear it.
2011
The company Avexima is created, which subsequently took over the management of pharmaceutical enterprises in the Sverdlovsk and Kemerovo regions. As a result, the company's assets were replenished with more than 100 drugs of various nosologies.
2011
Large-scale reconstruction and deep modernization of the chemical and pharmaceutical plant in Anzhero - Sudzhensk (Kemerovo region), the renaming of the enterprise to Avexima Siberia LLC.
2013
Large-scale reconstruction and deep modernization of the Irbit Chemical and Pharmaceutical Plant in the city of Irbit (Sverdlovsk region), the renaming of the enterprise to JSC Irbit Chemical and Pharmaceutical Plant.
2018
Acquisition of the Immafarma asset for the production of modern immunological drugs.
2020
Avexima receives the status of an accredited center for collective use of the Skolkovo Technopark.
2020
The Avexima Research Center, which is currently one of the largest scientific centers in Skolkovo, is starting work.
2021
Avexima Company signs a memorandum of partnership as part of a project to create the largest pharmaceutical cluster in the country in the Moscow region. In the same year, the company announced the launch of design work on the construction of a large-scale pharmaceutical industrial and logistics complex in the Esipovo Technopark.
2022
The approval procedure for the project documentation for the construction of the FPLK "Esipovo" has been completed, the relevant documents and the construction permit have been certified, and permission has been received to start construction work.
Dear colleagues and customers!
You are on the website of the Russian pharmaceutical company Avexima.
Our company is one of the leading manufacturers of not only innovative drugs, but also well-proven effective affordable high-quality drugs for the treatment of various diseases.
Today, the company's portfolio includes more than 120 medicines, many of which are included in the list of essential medicines. Avexima's production division is formed by several modern pharmaceutical plants:
Due to its own production base, Avexima is one of the unique pharmaceutical manufacturers, not only producing ready–made forms of medicines, but also synthesizing their basis - a medicinal substance. The entire drug production process undergoes careful quality control in modern laboratory complexes, which are equipped with all the company's plants.
Avexima is developing towards the development of new medicines. The modern Avexima research complex in the Skolkovo Technopark is one of the most modern research centers in the country.
This allows us not only to improve the quality
and to increase the effectiveness of the company's already manufactured drugs, but also to create new drugs for the treatment of current diseases.
Modern production, scientific development
In the field of pharmacology and the high professionalism of the staff, it is possible to create modern, high-quality and affordable medicines for consumers and form a solid foundation for the country's security in the field of medicines.
CEO
Having a serious scientific base, having experience and competencies in the field of pharmaceutical substances production and the release of medicines of any form, as well as successful promotion experience and existing contracts with major distributors and pharmacy chains, Avexima is open to cooperation in the field of contract manufacturing and services in the field of launching and selling products of companies-partners.
*when concluding a long-term contract
As part of the cooperation, the company's specialists in the field of production, promotion, and marketing will develop an optimal program for the withdrawal and promotion of drugs from the partner company, taking into account the partner's capabilities and expected revenue.